医疗保健巨头强生公司再次展现其稳健的财务实力，宣布实现连续第64个年度的股息增长，将季度股息上调3.1%。这一举措延续了该公司自1959年以来从未中断的股东回报传统。
本次股息调整后，强生每股季度现金股息提升至1.24美元，较此前1.19美元的水平有所增长。按照最新股息计算，年度化股息收益率达到约3.2%，在医疗保健板块中保持领先地位。
值得注意的是，强生此次股息增长恰逢公司进行业务重组的关键时期。在分拆消费者健康业务为独立上市公司Kenvue后，强生正专注于制药和医疗设备两大核心业务。分析师指出，持续增加的股息支付充分体现了公司对未来现金流稳定性的信心。
市场对此次股息上调反应积极，股价在盘前交易中小幅上扬。作为道琼斯工业平均指数的成分股，强生长期稳定的股息政策使其成为价值投资者青睐的防御型标的。截至目前，强生已是标普500指数中连续提高股息年限最长的企业之一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.